title: Developing point of care and high-throughput biological assays for determining absorbed radiation dose.
abstract: OBJECTIVE
  Systems are being developed to assess radiation exposure based on leukocyte mRNA levels obtained by finger-stick sampling. The goal is to provide accurate detection of dose exposures up to 10 Gy for up to 1 week following exposure. We previously showed that specific mRNA sequences increase expression within an hour of exposure, and some genes continue to show elevated expression for at least 24 h. Full duration and dose-dependence of this persistence remain to be determined. In the present study, real-time quantitative PCR (qPCR) was used to determine changes in gene expression. qPCR can rapidly analyze small blood samples and could be adopted into a field-portable instrument that provides a radiation dose readout within 30 min.
  
  
  METHODS
  From previous microarray analysis of 21,000 genes expressed in human lymphoblastoid cells 4 h post-irradiation (0-4 Gy), 118 genes were selected for evaluation by qPCR of gene expression in the leukocytes of human blood irradiated in vitro with doses of 0-10 Gy from a Co-60 gamma source at a dose rate of 30 cGy/min.
  
  
  RESULTS
  Blood from 20 normal healthy human donors yielded many mRNA sequences that could be used for radiation dosimetry. We observed four genes with large and persistent responses following exposure: ASTN2, CDKN1A, GADD45A, and GDF15. Five genes were identified as reliably non-responsive and were suitable for use as endogenous controls: DPM1, ITFG1, MAP4, PGK1, and SLC25A36; of these, ITFG1 was used for the analyses presented here. A significant dose-responsive increase in expression occurred for CDKN1A that was >16-fold at 10 Gy and 3-fold at 0.5 Gy compared to pre-irradiation values.
  
  
  CONCLUSIONS
  These data show large, selective increases in mRNA transcript levels that persist for at least 48 h after single exposures between 0.5 and 10 Gy. Stable, non-responsive mRNA sequences for use as endogenous controls were also identified. These results indicate that following further study to establish the most reproducible gene and dose-response models under a wide range of conditions in vivo, rapid real-time qPCR on blood samples could potentially be used to establish biologically-effective dosimetry from either accidental irradiation or clinical radiotherapy.
authors: Dept. of Radiation Oncology, Wayne State University, Detroit, MI 48201-2013, USA. joinerm@wayne.edu
authors: Michael C
authors: MC
authors: Joiner
authors: Robert A
authors: RA
authors: Thomas
authors: William E
authors: WE
authors: Grever
authors: Joseph M
authors: JM
authors: Smolinski
authors: George W
authors: GW
authors: Divine
authors: Andre A
authors: AA
authors: Konski
authors: Gregory W
authors: GW
authors: Auner
authors: James D
authors: JD
authors: Tucker
mesh_terms: D002478:Cells, Cultured / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005720:Gamma Rays; D020869:Gene Expression Profiling; D057166:High-Throughput Screening Assays; D006801:Humans; D008214:Lymphocytes / Q000528:radiation effects*; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D019095:Point-of-Care Systems; D016133:Polymerase Chain Reaction / Q000379:methods*; D012333:RNA, Messenger / Q000528:radiation effects*; D011829:Radiation Dosage; D011836:Radiation Tolerance / Q000235:genetics; D012680:Sensitivity and Specificity
chemical_list: D012333:RNA, Messenger